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Adherence to chronic Oral Anticoagulant Therapy (OAT) is directly related to patients’ 
understanding of the therapy. This study verified the knowledge of patients with mechanical 
valve prostheses concerning OAT. This is a contemporary cross-sectional study, the sample 
is composed of patients with mechanical valve prostheses (MVP) in outpatient follow-up. 
A 10-question instrument was used; answers were ‘know’ (1 point), ‘know partially’ (half 
point), or ‘do not know’ (zero). Patients were grouped according to the result obtained: 
≤ 4 points was considered insufficient knowledge; > 4 ≤ 8 equated to moderate knowledge; 
and > 8 was considered appropriate knowledge. Of the 110 patients, 61.8% presented 
moderate knowledge, 40.9% were not able to name at least one factor that may alter the 
INR (International Normalized Ratio) and 37.3% were not able to report their INR target 
range. The majority of patients presented moderate knowledge concerning the treatment. 
Strategies to improve knowledge on the topic should be implemented to minimize risks.
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Conhecimento de pacientes portadores de prótese valvar mecânica 
sobre a terapia com anticoagulação oral crônica
A adesão à terapia com anticoagulação oral crônica está diretamente relacionada ao 
entendimento dos pacientes sobre essa terapia. O objetivo deste estudo foi verificar o 
conhecimento dos pacientes, com prótese valvar mecânica, sobre terapia de anticoagulação 
oral. Como método, usou-se o estudo transversal contemporâneo. Incluem-se pacientes 
com prótese valvar mecânica (PVM) em acompanhamento ambulatorial. Aplicou-se 
instrumento com 10 questões. As respostas eram sabe (um ponto), sabe parcialmente 
(meio ponto), ou não sabe (zero). Os pacientes foram agrupados conforme a pontuação 
obtida. Considerou-se ≤4 pontos conhecimento insuficiente, >4 ≤8 conhecimento regular 
e >8 conhecimento adequado. Os resultados mostram que, dos 110 pacientes, 61,8% 
apresentaram conhecimento regular, 40,9% não souberam citar ao menos um fator que 
alterasse a razão normatizada internacional (RNI) e 37,3% não souberam informar o seu 
RNI alvo. Conclui-se que a maioria dos pacientes apresentou conhecimento regular sobre 
o tratamento. Estratégias devem ser implementadas para melhorar o conhecimento e, 
consequentemente, minimizar os riscos dessa terapêutica.
Descritores: Anticoagulantes; Enfermagem; Conhecimento; Próteses Valvulares 
Cardíacas.
Conocimiento de los pacientes portadores de prótesis valvular mecánica 
sobre la terapia de anticoagulación oral crónica
El objetivo de este estudio fue verificar el conocimiento de pacientes con prótesis valvular 
sobre la terapia de anticoagulación oral. La adhesión a la terapia de anticoagulación oral 
crónica está directamente relacionada al entendimiento del paciente sobre esta terapia. 
Se trata de un estudio transversal contemporáneo, en el cual se incluyeron pacientes 
de ambulatorio con prótesis valvular mecánica (PVM). Se aplicó un cuestionario con 
10 preguntas; las respuestas fueron “sabe” (1 punto), “sabe parcialmente” (medio 
punto), “no sabe” (cero puntos). Los pacientes fueron agrupados según la puntuación 
obtenida: ≤ 4 puntos, conocimiento insuficiente; > 4 ≤ 8 puntos, conocimiento regular; 
> 8 puntos, conocimiento adecuado. De los 110 pacientes incluidos, el 61,8% demostró 
conocimiento regular, 40,9% no supieron citar un factor que altera el REI (razón 
estandarizada internacional) y 37,3% no supieron informar su REI objetivo. Se concluyó 
que la mayoría de los pacientes demostró conocimiento regular sobre el tratamiento. Se 
recomienda implantar estrategias para mejorar el conocimiento y minimizar los riesgos 
de la terapia.
Descriptores: Anticoagulantes; Enfermería; Conocimiento; Prótesis Valvulares Cardíacas.
Introduction
Patients with mechanical valve prostheses need 
to receive chronic therapy with oral anticoagulants in 
order to reduce the occurrence of thromboembolic 
events(1). Treatment with oral anticoagulants consists 
of maintaining the International Normalized Ratio 
(INR), which allows one to evaluate the plasma 
clotting time within the therapeutic range values. 
The INR therapeutic values for aortic valve prosthesis 
are between 2.0 and 3.0 and between 2.5 and 3.5 
for mitral valve replacement, according to the World 
Health Organization(2-4). Nevertheless, this therapy 
has limitations in clinical practice due to the difficulty 
for health professionals of keeping patients’ INR 
values within therapeutic specifications. National and 
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international data indicate that 40% to 50% of patients 
undergoing oral anticoagulant therapy do not meet 
the target values, which leads to an increased risk of 
bleeding or thrombotic events(5-6).
The knowledge of patients concerning oral 
anticoagulant therapy is very diversified. The Early Self-
Controlled Anticoagulation Trial (ESCAT) verified that 
anticoagulant patients who used an electronic device to 
verify their INR at home had an improved survival rate 
of about 33%, compared to a group of individuals who 
did not use such a device(7). On the other hand, results 
of a similar study developed in São Paulo, Brazil did not 
present favorable results for the use of an electronic 
device(5). In another study involving knowledge of oral 
anticoagulants among different ethnic groups, only 9% 
of anticoagulant patients were able to name one or more 
of the adverse effects of anticoagulant medication(6).
A previous study indicates that knowledge 
concerning anticoagulants was associated with a reduced 
risk of bleeding(8) and that written and verbal information 
helped to improve control of anticoagulant levels(9).
Because there are few Brazilian studies addressing 
the issue and also considering that oral anticoagulation 
is directly related to the understanding of patients 
concerning their medication, its benefits and related 
adverse events, this study verified knowledge concerning 
the use of chronic anticoagulation treatment in patients 
with mechanical valve prostheses.
Method
A cross-sectional study was carried out between 
October 2007 and February 2008 in an outpatient 
clinic specializing in cardiology in two hospitals in Porto 
Alegre, RS, Brazil. Users of the Single Health System, 
18 years old or older, with mechanical valve prostheses, 
taking oral anticoagulation medication and who attended 
consultations in the clinic were included in the study. 
All patients included in the study were accompanied 
in this clinic and underwent valve replacement in the 
same studied institutions. No patients were excluded 
from the study. Data collection was carried out through 
an instrument composed of 11 questions: the ten 
first questions addressed knowledge and the last one 
the level of patient satisfaction regarding information 
received concerning oral anticoagulation medication.
The instrument contained the following options of 
responses: ‘know’, ‘know partially’ or ‘do not know’; 
a half point was awarded for ‘know partially’ and one 
point for ‘know’. Thus, based on a study that evaluated 
anticoagulant patients with several indicators, we 
considered insufficient knowledge as up to four points 
(inclusive), moderate knowledge from four to eight points 
(inclusive), and appropriate knowledge above eight 
points(10). The data collection instrument was adapted 
from a British study carried out by Sunil Nadar and 
colleagues(11), whose use was authorized by the group’s 
coordinator Gregory Y. H. Lip. The English version was 
initially translated to Portuguese and then submitted to 
face validation(12). This stage involved a multidisciplinary 
team and researchers in the field; idiomatic, semantic, 
cultural and conceptual equivalences were performed in 
order to improve the consensus concerning the instrument. 
Hence, the instrument was evaluated by six judges who 
were health professionals directly or indirectly involved 
with anticoagulant patients (two physicians, two nurses 
and two nutritionists). All suggestions were considered, 
including the exclusion of a dubious question that was 
also different form the other constructs.
The instrument that verifies the knowledge of 
patients regarding oral anticoagulant therapy was 
directly applied to the patients by the study’s researcher, 
after securing their agreement, in the outpatient clinic 
itself on the days the patients’ OATs were scheduled. 
A pilot test was carried out before data collection with 
ten patients to refine the instrument. There were not 
100% of answers ‘know partially’ or ‘do not know’ for 
any questions and no patients answered ‘know partially’ 
or ‘do not know’ to all questions. Therefore, all questions 
were maintained.
The sample was computed in such a way the 
instrument was applied to ten patients per question, 
which is recommended to evaluate internal reliability 
through Cronbach’s alpha(13).
This study was approved by the Ethics Research 
Committee of both institutions (N. 4029/07) and all 
patients were included after reading and signing free 
and informed consent forms.
Statistical Analysis
Data were analyzed through the Statistical Package 
for Social Sciences, version 12.0. All categorical 
variables were expressed in absolute numbers and 
their percentages; continuous variables were described 
with average ± standard deviation or median and 
percentiles 25 and 75, as they fit normal distribution 
or not. Person’s correlation was used to evaluate the 
correlation between the obtained score and the studied 
variables such as ‘time of surgery’ and ‘schooling’. To 
compare the score average in relation to the variables 
‘gender’ and ‘professional status’, the t test was used. 
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In relation to the comparison between the score and the 
position of the valve prosthesis, variance analysis was 
used. Cronbach’s reliability test was used to evaluate 
and measure the internal consistency of the applied 
questionnaire while the values > 0.7 were considered 
ideal to evaluate consistency of the same construct(13).
Results
A total of 110 patients were evaluated. The internal 
consistency, evaluated through Cronbach’s alpha, was 
0.627. Average age was 50.3±10.7 years old and 
58.2% were female; average of years of schooling 
was 6.07±2.98 years and 44.5% of the patients were 
retired. Mitral valve replacement (62.7%) and the use of 
warfarin as anticoagulant (64.5%) predominated. Data 
are shown in Table 1.
Table 1 – Characteristics of a sample of anticoagulant 
patients in a specialized outpatient clinic (n= 110). Porto 
Alegre, RS, Brazil 2009
Characteristics n (%)
Age* 50.3±10.7
Gender (male) 46 (41.8)
Years of Schooling * 6.07±2.98
Surgery Data
from 1980 to 1997 19 (17.1)
from 1998 to 2002 47 (42.7)
from 2003 to 2007 44 (40)
Race (Caucasian) 97 (88.2)
Categorical data are presented with n (%);*Variable expressed with 
average ± standard deviation
Most of the patients were able to report the 
name of the oral anticoagulant they were using, the 
medication’s function, why they were using it, and 
the dose they were currently using. We highlight 
that 36% of the patients were not able to name at 
least one side effect of the oral anticoagulant. Of the 
interviewed patients, 10.9% were not able to tell what 
could happen if they did not take the anticoagulant and 
37.3% did not know what the their ideal INR value was. 
When asked about factors that could interfere in their 
INR, 40.9% answered ‘do not know’ and nor were they 
able to name at least one factor that could interfere 
in it. Also, 21.8% of the sample was not able to list 
the precautions they should take given the use of the 
therapy (Table 2).
Questions know Know partially Do not know
1. What is the name of the anticoagulant you are taking? 109 (99.1) - 1 (0.9)
2. Do you know the function of this medication? 103 (93.6) 5 (4.5) 2 (1.8)
3. Do you know why you are taking this medication? 76 (69.1) 16 (15.5) 18 (16.4)
4. Can you tell what the OAT side effects are? (At least 1). 46 (41.8) 28 (25.5) 36 (32.7)
5. What is the dose of OAT you are currently taking? 107 (97.3) 3 (2.7) -
6. How long have you been taking OAT? 110 (100) - -
7. What can happen if you do not take OAT? 72 (65.5) 26 (23.6) 12 (10.9)
8. What is your target INR? 55 (50) 14 (12.7) 41 (37.3)
9. Do you know what factors can interfere with your INR levels? (At least 1). 43 (39.1) 22 (20) 45 (40.9)
10. Do you know what precautions you have to take due to the use of OAT? (At least 2: physical 
exercise, identification card, diet, activities before procedures, INR periodical control). 44 (40) 42 (38.2) 24 (21.8)
Characteristics n (%)
Professional status 
Working 18 (16.4)
Retired 49 (44.5)
Unemployed 27 (24.5)
Sick leave 16 (14.5)
Position of prosthesis 
Mitral 69 (62.7)
Aortic 31 (28.2)
Mitral and aortic 10 (9.1)
Anticoagulant (warfarin) 71 (64.5)
Continue...
Table 1 – Continuation
Table 2 – Knowledge of patients concerning chronic anticoagulant therapy. Porto Alegre, RS, Brazil 2009
INR: International Normalized Ratio; OAT: Oral Anticoagulation Therapy. Categorical Data are presented with n (%).
In relation to the score obtained in the instrument, 
the majority (68; 61.8%) presented regular knowledge, 
followed by 40 (36.4%) patients who had good knowledge 
and two (1.8%) who had poor knowledge.
Correlation between anticoagulation time and 
the instrument score was evaluated and was not 
significant (r=0.183; P=0.056). Evaluating the age 
of the interviewees and score obtained revealed a 
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significant inverse correlation (r=-0.248; P=0.009). In 
the items ‘schooling’ and ‘correct answers’, a positive 
and significant, though weak correlation, was found 
(r=0.276; P=0.03).
There were no differences between gender and 
score obtained in the questionnaire and professional 
status. We note that patients with mitral and aortic valve 
prostheses (9.1%) obtained better average, 8.45±0.95, 
though not statistically significant.
Discussion
This study aimed to verify knowledge of the use of 
chronic oral anticoagulation in patients with mechanical 
valve prostheses. It showed that patients presented 
regular knowledge about oral anticoagulant therapy and 
there was no relation between gender and professional 
status with knowledge score. The results of another study 
conducted in the nursing field in which 64% of patients 
answered correctly almost the entire questionnaire 
addressing oral anticoagulation knowledge with the 
exception of one question addressing the influence of 
diet, were similar(10). However, the results of this study 
differ from those found by other researchers who 
evaluated patients with mechanical valve prostheses 
and evidenced poor knowledge regarding warfarin 
therapy. This same study evidenced that the predictors 
of a better understanding of treatment were knowing the 
meaning of INR, being young and obtaining information 
concerning anticoagulation upon hospital discharge(14).
The scenarios of clinical practice in which patients 
control the levels of anticoagulation are diversified, 
especially in relation to professionals in the health field 
and the way information is transmitted to patients. In 
mid 1950s, scientific thinking concerning the success 
of anticoagulation therapy was composed of four main 
variables: medical surveillance, reliable laboratory work, 
easily available exams and collaboration of patients with 
the treatment(15). Over the years, one of the variables 
experienced an important and necessary development. 
Due to the increasing number of anticoagulant patients, 
medical surveillance now includes outpatient follow-up 
performed by other health professionals, among whom 
nurses are included. In this context, anticoagulation 
outpatient clinics, especially those directed to the 
monitoring of therapeutic practices associated with 
patients’ education, emerged(16).
The most important factor in treatment success 
is periodical and careful follow-up of INR levels and 
assurance that patients will adhere to the treatment, 
which is a difficult task for clinical practice(17-19). Despite 
the practical relevance of teaching patients regarding 
their therapy, a best strategy to educate patients about 
anticoagulation has yet to be determined(20).
Recent European studies indicate that anticoagulation 
self-regulation that the patient controls when s/he is 
taught is a successful strategy. Self-control is realized 
through a rapid test device, in which the patient adjusts 
the dose of his/her medication. Studies conducted from 
this perspective have shown that patients are able to 
keep their INR within therapeutic range longer and 
also show improved survival and diminished adverse 
effects(1,3,21).
Studies involving other approaches for 
anticoagulation control such as telephone contact, also 
present positive results, both for patients and the team 
monitoring them(22).
About half of this study’s sample knew their target 
INR values and this information agrees with that found by 
a British study, in which more than half of patients knew 
the interval of their therapeutic INR. This British study 
carried out an educational program with intervention, 
which improved the knowledge of patients about the 
factors that might interfere with anticoagulation levels(23). 
A significant share of the sample of the present study did 
not know what these factors are. In relation to the risks 
of treatment and its side effects, American researchers 
presented as an alternative the use and supply of a visual 
scale the illustrations of which are meant to demonstrate 
what might happen if the levels of anticoagulation are off 
the target values. The benefit of using this visual scale was 
significant to patients who had difficulty understanding 
the scheme of dosages that resulted in poor control of 
their anticoagulation levels(24).
An expressive number of patients who were not 
able to mention at least one side effect was found in the 
present study; they were unaware there was a possibility 
of bleeding. The number of patients in this sample who 
were not able to list care related to the therapy is also 
noteworthy, such as medication interaction, the influence 
of a diet rich in vitamin K, and necessary care before 
invasive procedures (extractions for example). They 
only mention monthly laboratorial control as the main 
necessary care. It is known that a successful therapy 
requires the adherence of patients, which enables 
maximum knowledge concerning anticoagulant therapy 
to be transmitted. Nurses and other professionals 
are expanding the boundaries of their practice in 
anticoagulation outpatient clinics to improve the stability 
of patients’ INR.
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The patients’ return visits to the anticoagulation 
outpatient clinic should be an opportunity to 
investigate difficulties they face, especially among 
those who are not able to keep anticoagulation 
within appropriate levels. The patients’ educational 
process has began a new era in which educational 
results should take into account the level of patients’ 
literacy, barriers to learning and cost-effectiveness 
relationships, giving priority to educational content 
and using validated instruments to measure the 
results of instruction provided(25). It is necessary to 
recognize that the assisted individuals develop, due 
to their experiences, a certain understanding of 
procedures and recommendations defended by the 
health services and, consequently, certain attitudes 
in relation to them. Thus, scientific knowledge needs 
to be contextualized, confronted and approximated to 
other types of knowledge, especially folk knowledge 
so it becomes useful knowledge(26). Additionally, it 
is necessary that health professionals welcome and 
establish bonds with the individuals they are assisting, 
respecting their autonomy in relation to their way of 
life(26). These competencies include listening to patients 
acknowledge their health needs, establishing close 
and candid relationships, and relating and integrating 
with the assisted individuals.
Final Considerations
The majority of patients included in this study 
presented regular knowledge concerning their 
anticoagulant therapeutic, especially in relation to 
side effects, factors that interfere in their INR levels 
and care required by oral anticoagulant therapy. Given 
these findings, we suggest patients with mechanical 
valve prostheses have a multidisciplinary approach 
initiated during hospitalization, reinforced at the point 
of discharge and to last at least six to twelve months 
or until the patient is stable and familiarized with the 
therapy and his/her INR level.
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